(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-butoxypropanoic acid, 98%, 250mg

1-Cyclohexyl-3-(2-morpholinoethyl)carbodiimide Metho-p-toluenesulfonate [for Peptide Synthesis]>96.0%(N)(T)25g

(E)-4-((2-((2-isonicotinoylhydrazono)methyl)phenoxy)methyl)benzoic acid, 97%, 1g

4-Iodopentylbenzene, 99.0%, 5g

4-(Methylsulfonyl)aniline, 97.0%, 500g

2'-chloro-4'-fluoro-3-(3-methylphenyl)propiophenone, 97.0%, 1g

4,4,5,5-Tetramethyl-2-(4-propoxyphenyl)-1,3,2-dioxaborolane, 98%, 1g

Methyl 2-chloro-3-hydroxybenzoate, 95.0%, 250mg

Báscula de precisión serie EHA, 0,1 g, 1000 g, EHA 1000-1

5-Bromo-3-methoxypyridin-2-amine, 95.0%, 25g

1-(4-Bromobenzoyl)piperidine, 95.0%, 250mg

4-Bromo-2-fluoro-4'-morpholinomethyl benzophenone, 97.0%, 1g

3-bromo-5-((S)-1-((S)-tert-butylsulfinyl)pyrrolidin-2-yl)pyridine, 98%, 1g